Atopic Dermatitis Treatments
Find Atopic Dermatitis Treatments
Brand Name
Eucrisa
Generic Name
Crisaborole
View Brand Information FDA approval date: January 30, 2017
Classification: Phosphodiesterase 4 Inhibitor
Form: Ointment
What is Eucrisa (Crisaborole)?
EUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older. EUCRISA is a phosphodiesterase 4 inhibitor indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment